Infectious Agents and Cancer

Papers
(The H4-Index of Infectious Agents and Cancer is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination65
Epidemiology of high-risk human papillomavirus among women of the north-central region of Ecuador: a retrospective study48
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population39
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses33
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status30
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation30
Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors28
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker27
The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review26
Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?26
Mendelian randomization in cancer research: opportunities and challenges24
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients23
Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study23
Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China23
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma22
Investigation of the presence of cervical human papillomavirus and the distribution of preinvasive lesions in patients using immunomodulators-Inosine Pranobex22
Single-cell analysis reveals the regulatory role of ECT2 in HPV-driven cervical carcinogenesis process22
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis21
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 20
Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa19
Precision therapeutic targets for HPV-positive cancers: an overview and new insights19
0.059428215026855